BiomX Inc. 8-K/A

What Happened

• BiomX Inc. (PHGE) filed an 8‑K (Item 9.01) on June 12, 2026 to furnish financial statements for two subsidiaries, Zorronet and DFSL. The filing adds: audited consolidated financial statements as of and for the years ended December 31, 2025 and 2024, and unaudited condensed financial statements as of and for the three months ended March 31, 2026 and 2025 for each subsidiary.

Key Details

• Filing date: June 12, 2026 (Form 8‑K, Item 9.01).
• Audited statements included: consolidated financials for years ended Dec 31, 2025 and Dec 31, 2024 for Zorronet and DFSL.
• Quarterly statements included: unaudited condensed financials for the three months ended Mar 31, 2026 and Mar 31, 2025 for both subsidiaries.
• The 8‑K indicates these statements are being added to the Original Reports and update previously filed information.

Why It Matters

• The filing provides investors with audited annual and unaudited quarterly financial detail for Zorronet and DFSL, improving transparency about those subsidiaries' financial positions and quarterly results.
• This 8‑K itself does not announce consolidated earnings, executive changes, or a transaction; it supplies subsidiary financials that investors and analysts can use when assessing BiomX’s consolidated financials and potential impacts on revenue or expenses.